Genomate Health Resources

Genomate Health Brings Genomics-Driven Cancer Second Opinion to U.S. Patients

Genomate Health at JPM 2026

January 11–15

Genomate applied to complex HER2 positive, ER/PR positive grade III invasive carcinoma

Patient Stories

AI in ONCOLOGY 2026: Clinical efficacy of computational reasoning for personalized treatment planning in a pan-cancer cohort discussed by a French multidisciplinary tumor board

Publications

AI in ONCOLOGY 2026: Clinical efficacy of computational reasoning for personalized treatment planning in a pan-cancer cohort discussed by a French multidisciplinary tumor board

Barbara Vodicska, Eniko Kispeter, Dora Lakatos, Gabor Gyorgy Kalmar, Robert Doczi, Dora Gorog-Tihanyi, Anna Dirner, William T Beck, Ivan Bièche, Edith Borcoman, Nicolas Servant, Kenza Nedara, Sarah Watson, Célia Dupain, Istvan Petak, Christophe Le Tourneau

AACR: Clinical efficacy of Genomate for personalized treatment planning in a real-world pan–cancer cohort discussed by a French MTB

Barbara Vodicska, Eniko Kispeter, Dora Lakatos, Gabor Gyorgy Kalmar, Robert Doczi, Dora Gorog-Tihanyi, Anna Dirner, William T Beck, Ivan Bièche, Edith Borcoman, Nicolas Servant, Kenza Nedara, Sarah Watson, Célia Dupain, Istvan Petak, Christophe Le Tourneau

AACR: Molecularly-Informed Prediction of Treatment Efficacy in the GENIE BPC NSCLC Cohort using computational reasoning

Barbara Vodicska, Eniko Kispeter, Dora Lakatos, Gabor Gyorgy Kalmar, Robert Doczi, Dora Gorog-Tihanyi, Anna Dirner, Reka Szalkai-Denes, William T Beck, Arkadiusz Z. Dudek, Christophe Le Tourneau, Istvan Petak

Latest Events

Genomate Health at JPM 2026

January 11–15

San Francisco, CA

January 11–15

San Francisco, CA

Genomate at AACR-KCA 2025

November 11–20, 2025

November 11–20, 2025

Patient Stories

See all

Genomate applied to complex HER2 positive, ER/PR positive grade III invasive carcinoma

No items found.

Latest News

Genomate Health Brings Genomics-Driven Cancer Second Opinion to U.S. Patients

Genomate Health contributes to major EU-funded COMPASS cardio-oncology initiative

Genomate Health Expands Global Footprint with Acquisition of Oncompass Medicine

January 14, 2026

Opinions

You’ve Done Tumor Sequencing, Why Don’t You Have Clear Treatment Options?

When Should You Get a Second Opinion in Cancer Care? (And When It Matters Most)

Why Genomic Testing Alone Is Not Enough in Precision Oncology

Media Coverage

Genomate Health launches AI-powered cancer treatment service to close precision oncology gap

Many Cancer Patients Leave Treatment Options on the Table - You Don’t Have To

GenomeWeb Best Places to Work: Genomate Health

November 19, 2025

Award banner - genomeweb, best place to work 2025

The Genomate® Report can be used and clinically interpreted only by physicians or other qualified healthcare professionals. Genomate® is a clinical decision support software and is not intended to diagnose, treat, cure, prevent, or mitigate any condition. None of the statements contained herein have been evaluated by the U.S. Food and Drug Administration. Learn more.